23andMe Taps Dechert To Review CEO Buyout Proposal

By Al Barbarino · April 18, 2024, 5:21 PM EDT

A special committee of genetic testing company 23andMe has engaged Dechert LLP as its legal adviser and Wells Fargo as its financial adviser as it looks to review an anticipated buyout...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Recent Articles By Al

April 30, 2024
PE-Backed Medline Buying Ecolab's Surgical Unit For $950M
April 29, 2024
Deciphera Stock Soars On $2.4B Deal With Japan's Ono
April 24, 2024
Private Equity Lag Continues To Stunt M&A Growth
April 09, 2024
Tech M&A Reigns Supreme In Q1 After Rare Hiccup In Q4
April 05, 2024
Freshfields Reps J&J On $13.1B Deal For Shockwave Medical
March 25, 2024
Paul Weiss-Led AbbVie Inks Up To $212M Deal For Landos Bio
March 25, 2024
Kirkland Guides Ingersoll Rand On $2.3B ILC Dover Buy
March 19, 2024
IFF Selling Pharma Unit To French Co. Roquette In $2.85B Deal
February 12, 2024
Gilead Buying Liver Disease Drugmaker CymaBay For $4.3B
February 05, 2024
Novo Holdings Buying Biopharma Co. Catalent In $16.5B Deal